Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series.
Ashok AspatwarNanda Kumar ParvathaneniHarlan BarkerEmilie AnduranClaudiu T SupuranLudwig J DuboisPhilippe LambinSeppo ParkkilaJean-Yves WinumPublished in: Journal of enzyme inhibition and medicinal chemistry (2020)
With the aim to obtain novel compounds possessing both strong affinity against human carbonic anhydrases and low toxicity, we synthesised novel thiourea and sulphonamide derivatives 3, 4 and 10, and studied their in vitro inhibitory properties against human CA I, CA II and CA IX. We also evaluated the toxicity of these compounds using zebrafish larvae. Among the three compounds, derivative 4 showed efficient inhibition against hCA II (KI = 58.6 nM). Compound 10 showed moderate inhibition against hCA II (KI = 199.2 nM) and hCA IX (KI = 147.3 nM), whereas it inhibited hCA I less weakly at micromolar concentrations (KI = 6428.4 nM). All other inhibition constants for these compounds were in the submicromolar range. The toxicity evaluation studies showed no adverse effects on the zebrafish larvae. Our study suggests that these compounds are suitable for further preclinical characterisation as potential inhibitors of hCA I, II and IX.
Keyphrases
- endothelial cells
- photodynamic therapy
- oxidative stress
- neoadjuvant chemotherapy
- induced pluripotent stem cells
- pluripotent stem cells
- stem cells
- emergency department
- squamous cell carcinoma
- high intensity
- risk assessment
- protein kinase
- mesenchymal stem cells
- locally advanced
- zika virus
- oxide nanoparticles
- capillary electrophoresis
- clinical evaluation